The utility of routine clinical 12-lead ECG in assessing eligibility for subcutaneous implantable cardioverter defibrillator
暂无分享,去创建一个
Erick A. Perez Alday | Larisa G. Tereshchenko | Muammar M. Kabir | Jason Thomas | Christopher Hamilton | Eugene A. Park
[1] Chun Wai Wong,et al. Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review , 2017, Heart.
[2] Wojciech Zareba,et al. Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol. , 2017, American heart journal.
[3] A. Sittig,et al. Reconstruction of the Frank vectorcardiogram from standard electrocardiographic leads: diagnostic comparison of different methods. , 1990, European heart journal.
[4] Michael R Gold,et al. Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. , 2017, Heart rhythm.
[5] Fabrizio Ammirati,et al. Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators , 2017, HeartRhythm case reports.
[6] Joaquín Osca,et al. Conventional and right‐sided screening for subcutaneous ICD in a population with congenital heart disease at high risk of sudden cardiac death , 2017, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[7] Iacopo Olivotto,et al. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. , 2016, Heart rhythm.
[8] Theodore C Chan,et al. Electrocardiographic electrode misplacement, misconnection, and artifact. , 2012, The Journal of emergency medicine.
[9] Kevin M. Monahan,et al. Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator , 2017, HeartRhythm case reports.
[10] Arthur A M Wilde,et al. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. , 2015, International journal of cardiology.
[11] A. Wilde,et al. Which Patients Are Not Suitable for a Subcutaneous ICD: Incidence and Predictors of Failed QRS‐T‐Wave Morphology Screening , 2014, Journal of cardiovascular electrophysiology.
[12] Rishi Arora,et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. , 2014, Heart rhythm.
[13] Pier D Lambiase,et al. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study. , 2017, Journal of the American College of Cardiology.
[14] Jonathan Weinstock,et al. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience , 2016, Journal of the American Heart Association.
[15] Marek Malik,et al. Incorrect electrode cable connection during electrocardiographic recording. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] J. Hummel,et al. T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator , 2017, HeartRhythm case reports.
[17] Pier D Lambiase,et al. Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy , 2017, Circulation. Arrhythmia and electrophysiology.
[18] Nandita Sharma,et al. Visual transform applications for estimating the spatial QRS-T angle from the conventional 12-lead ECG: Kors is still most Frank. , 2014, Journal of electrocardiology.
[19] SumChe Man,et al. Influence of the vectorcardiogram synthesis matrix on the power of the electrocardiogram-derived spatial QRS-T angle to predict arrhythmias in patients with ischemic heart disease and systolic left ventricular dysfunction. , 2011, Journal of electrocardiology.
[20] Pier D. Lambiase,et al. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. , 2015, Journal of the American College of Cardiology.